GACM
GILD icon

Green Arrow Capital Management’s Gilead Sciences GILD Stock Holding History

Green Arrow Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-30,000
Closed -$2.13M – 202
2014
Q1 		$2.13M Sell
30,000
-58,889
-66% -$4.62M 0.18% 151
2013
Q4 		$6.68M Buy
+88,889
New +$6.19M 0.47% 71

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Green Arrow Capital Management's GILD Position: Q2 2014 in Review

Green Arrow Capital Management sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 30,000 shares — an estimated $2.13M sold.

Green Arrow Capital Management first reported a position in GILD in Q4 2013 and held it in 2 quarters. The position peaked at $6.68M in Q4 2013. 1,262 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Green Arrow Capital Management reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 30,000 Gilead Sciences shares in Q2 2014, an estimated $2.13M.
  • Green Arrow Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 2 quarters.
  • Green Arrow Capital Management's Gilead Sciences position peaked at $6.68M in Q4 2013.
  • 1,262 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Green Arrow Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.